Determination and optimization of the mechanism of action for efficacy of Gleevec in the type I diabetes NOD mouse model
-
Investigator: Jeffrey Bluestone, PhD
Sponsor: Genomics Inst of the Novartis Resrch Fdn
Location(s): United States
Description
no description available